KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ionis Pharmaceuticals (IONS) EPS (Weighted Average and Diluted): 2009-2024

Historic EPS (Weighted Average and Diluted) for Ionis Pharmaceuticals (IONS) over the last 15 years, with Dec 2024 value amounting to -$3.04.

  • Ionis Pharmaceuticals' EPS (Weighted Average and Diluted) rose 15.79% to -$0.80 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.69, marking a year-over-year increase of 30.74%. This contributed to the annual value of -$3.04 for FY2024, which is 18.75% down from last year.
  • As of FY2024, Ionis Pharmaceuticals' EPS (Weighted Average and Diluted) stood at -$3.04, which was down 18.75% from -$2.56 recorded in FY2023.
  • In the past 5 years, Ionis Pharmaceuticals' EPS (Weighted Average and Diluted) registered a high of -$0.20 during FY2021, and its lowest value of -$3.18 during FY2020.
  • For the 3-year period, Ionis Pharmaceuticals' EPS (Weighted Average and Diluted) averaged around -$2.50, with its median value being -$2.56 (2023).
  • Per our database at Business Quant, Ionis Pharmaceuticals' EPS (Weighted Average and Diluted) skyrocketed by 93.71% in 2021 and then slumped by 850.00% in 2022.
  • Over the past 5 years, Ionis Pharmaceuticals' EPS (Weighted Average and Diluted) (Yearly) stood at -$3.18 in 2020, then skyrocketed by 93.71% to -$0.20 in 2021, then crashed by 850.00% to -$1.90 in 2022, then plummeted by 34.74% to -$2.56 in 2023, then fell by 18.75% to -$3.04 in 2024.